The Ultherapy Prime Thermage FLX sequence protocol at Kind Global Clinic Myeongdong pairs 4.5mm SMAS-layer HIFU (₩1,090,000 (≈ $779) for 300 shots) with dermal monopolar radiofrequency (₩1,990,000 (≈ $1,421) for 600 shots) — either in one co-director-planned visit or staged 4 or more weeks apart, with the sequence set by SMAS grading, not by a menu.
The two platforms do different jobs at different depths, which is the entire logic of sequencing them. Ultherapy Prime, the Merz micro-focused ultrasound (MFU-V) system, fires focused ultrasound points that coagulate tissue at 65 to 70 degrees Celsius along the SMAS layer at 4.5mm, plus 3.0mm and 1.5mm passes — that is the lifting vector. Thermage FLX, the Solta monopolar radiofrequency platform, bulk-heats the dermis and subdermal collagen with its 4.0cm2 tip — that is the surface-tightening and texture vector. A face with jowl descent and loose dermal quality often shows more change from the two planes treated in sequence than from doubling shots on either single platform, which is the pattern Korean combination research supports: a Korean study of monopolar radiofrequency plus intense focused ultrasound reported moderate-or-greater improvement in 90 percent of treated patients (Kwon 2018).
Sequence and spacing are clinical decisions, not package labels. At Kind Global Clinic Myeongdong, the co-director — Dr. Lee Wonjin or Dr. Lee Kangin — grades your SMAS-layer laxity on the Prime real-time display during a 15-to-20-minute consultation, then writes the sequence into an itemized quote built only from published tiers: Ultherapy Prime 300 shots at ₩1,090,000 (≈ $779), 600 shots at ₩2,090,000 (≈ $1,493), and Thermage FLX 600 shots at ₩1,990,000 (≈ $1,421). There is no bundled combo price to decode — the combined plan is the sum of the published components, quoted in writing before any payment, with the same KRW figure for international and Korean patients.